+91-9896593699
Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.
EGFR mutation testing is essential part of work up of advanced NSCLC.Based on a paper puplished in 2015 looking into trends of EGFR mutation analysis in clinical practice, it was noted that EGFR genetic testing was not conducted in 19% of advanced
View DetailsERA OF PERSONALISED MEDICINE IN METASTATIC ADENOCARCINOMA LUNG:Stage IV adenocarcinoma is not a single disease. Different molecular subtypes of NSCLC have been identified and the treatment approach is different for each subtype.The different mole
View DetailsLiquid biopsy in non small cell lung cancer is now being used for detection of EGFR mutation analysis in patients who do not have accessible tissue for conventional testing and based on the platform used for liquid biopsy ie digital v/s nondigital it
View DetailsDecoding Lynch syndrome -- Colorectal cancer(CRC)Lynch syndrome is the most common cause of inherited Colorectal cancer (CRC-large intestine cancer). It constitutes 3% of all newly diagnosed colorectal cancer burden.In lynch syndrome there is ger
View DetailsMaintenance with PARP inhibitor is the way forward in ovarian cancer:Median PFS in platinum sensitive relapse carcinoma ovary is approximately 10 months.20% of high grade serous carcinoma ovary have somatic or germline mutation in BRCA gene.Sin
View DetailsRedefining low grade glioma ( a type of brain tumor ) using WHO 2016 classification:Clinical presentation of low grade glioma is usually with new onset seizureRadiologically low grade glioma are hyperintense on T2 MRI images and do not show contr
View DetailsCML (chronic myeloid leukemia) is a cancer that affects bone marrow and blood.The diagnosis of CML is confirmed by presence of Philadelphia chromosome on cytogenetics or FISH or by detecting bcr-abl by PCR.It has 3 phases chronic, accelerated and b
View DetailsTargeted therapy with gefitinib or erlotinib for 2 years is better than chemotherapy as adjuvant in resected non small cell lung cancer stage l to llla with EGFR mutation. The result suggest better disease free survival, however overall survival data
View Details